$EVER

Canaccord raises EverQuote stock price target on strong Q3 results

Canaccord raised its EverQuote (EVER) price target to $32 from $28, citing strong Q3 results. Revenue grew 24% YoY, with auto and home revenue gains. Q4 outlook exceeded consensus. EverQuote expects $1B annual revenue in 1-2 years. Shares trade at a P/E of 7.82. B.Riley also raised its target to $35, highlighting strong metrics.

Original reporting
Published Nov 3, 2026, 9:51 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 9:56 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$EVER
Bullish
high confidence
Mentioned
$EVER
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$EVERBullishMed
01

Why it matters

The earnings beat and target raise provide a clear catalyst for short‑term price appreciation.

02

Market read

First report of EverQuote's Q3 earnings and analyst upgrade, offering actionable insight for traders.

03

What to watch

Potential headwinds from a soft insurance market cycle extending to 2029.

Relevance 7/10Novelty 7/10Timing: pre-market today

Background

EverQuote posted Q3 2026 results with revenue of $218.1M and EPS of $0.49, both above expectations, and raised its FY outlook.

Company-level read

Ticker impact

$EVERBullishHigh confidence
Context

Canaccord raised its price target on EverQuote to $32 and reported Q3 revenue and EBITDA beating estimates.

Expected impact

likely upward pressure as investors price in the higher target and strong Q3 results

Evidence & confidence

Earnings beat, margin expansion, and a higher price target are fresh, material information that can move the stock immediately.

Market effects

Strong performance may boost sentiment in the online insurance brokerage sector.

Positive for U.S. tech‑enabled insurance platforms.

Limited to U.S. equity markets.

Counterpoint

The stock may already be priced for growth; further upside could be limited if margins compress.

Key entities

  • EverQuote

    Online insurance marketplace (NASDAQ:EVER).

  • Canaccord

    Equity research firm that raised the price target.

Related articles

$EVERMed

EverQuote: Q3 Earnings Snapshot

EverQuote reported Q3 net income of $18.2M, or 49 cents per share, with adjusted EPS of 72 cents. Revenue was $218.1M, exceeding analysts' estimates. The company expects Q4 revenue between $213M and $223M, according to Zacks Investment Research.

$EVERHigh

EverQuote (EVER) Q3 2026 Earnings Call Transcript

EverQuote (EVER) reported Q3 2026 earnings, exceeding guidance with 25% revenue growth to $218.1M and 41% adjusted EBITDA growth to $35.5M. The company highlighted strong performance in home insurance (70% YoY growth) and AI-driven initiatives, including new AI-native platforms and partnerships. The board authorized a $50M share repurchase program. Q4 2026 guidance projects 12% revenue growth.

$EVERMed

What EverQuote (EVER) Said on Its Q3 Earnings Call

EverQuote (EVER) reported Q3 operating cash flow of $40.5M, $229.1M in cash, and no debt. The board approved a $50M share buyback program. The company highlighted AI initiatives, including SmartCampaigns and the launch of Luva, an AI-native insurance platform. For Q4, EverQuote expects revenue of $213M-$223M, variable marketing dollars of $57M-$60M, and adjusted EBITDA of $29M-$32M, with a long-term goal of $1B in annual revenue.